サンプル依頼リスト カート
  • English
  • Korean
表紙：臨床腫瘍学向け次世代シーケンサー市場：ワークフロータイプ別、技術別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
市場調査レポート
商品コード
1364700

臨床腫瘍学向け次世代シーケンサー市場：ワークフロータイプ別、技術別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測

Clinical Oncology Next Generation Sequencing Market, By Workflow Type, By Technology, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 269 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
臨床腫瘍学向け次世代シーケンサー市場：ワークフロータイプ別、技術別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

臨床腫瘍学次世代シーケンス市場規模は2022年に3億8,840万米ドルとなり、2023年から2030年にかけてCAGR 16.5％で拡大

臨床腫瘍学次世代シーケンス市場-市場力学

がんの有病率の上昇が、臨床腫瘍学次世代シーケンス市場の成長を促進すると予測されます。

がんの有病率の上昇に伴い、疾患をより深く理解し、新薬を発見する必要性が高まっています。次世代シーケンシング（NGS）アッセイは、進行がん患者の治療において急速に好ましい選択肢となりつつあります。NGSアッセイは、高スループットのDNAシーケンシング技術を用いて、全ゲノム、全エクソーム、または特定の遺伝子エクソン（標的パネル）の配列を決定します。米国では2020年、新たに160万3,844人のがん患者が報告され、60万2,347人ががんで死亡しました。人口10万人当たり、403人の新規がん症例が報告され、144人ががんで死亡しました。疾病予防管理センターによると、2020年は罹患率データが入手可能な最新の年です。さらに、次世代シーケンサーは新たながん研究発見の入り口を開き、新たながん進行経路やプロセスを発見する可能性があります。これは市場に成長機会をもたらします。しかし、NGS技術とインフラに必要な初期投資のコストが高いため、市場の成長が制限される可能性がある、

臨床腫瘍学次世代シーケンス市場-セグメンテーション分析：

世界の臨床腫瘍学次世代シーケンシング市場は、ワークフロータイプ、アプリケーション、テクノロジー、エンドユーザー、地域に基づいてセグメント化されます。

市場はワークフローに基づいて3つのカテゴリーに分けられる：NGSプレシーケンス、NGSシーケンス、NGSデータ解析です。NGSシーケンシングセグメントが市場を独占しています。NGSは、旧来のアプローチよりも大幅に高速かつ安価なDNAおよびRNAシーケンスを可能にする、現在のシーケンス技術の一群を指します。これらの技術には、数百万から数十億のDNA分子の配列を同時に決定する能力があります。

市場は技術によって3つのカテゴリーに分けられる：全ゲノムシーケンス、全エクソームシーケンス、ターゲットシーケンスと再シーケンス。Targeted Sequencing and resequencingセグメントが市場の成長を支配しています。ターゲットシーケンスでは、全ゲノムをシーケンスするのではなく、疾患との関連が確認されている、または疾患との関連が疑われる特定の遺伝子または関心領域に焦点を当てます。以前にシーケンスされたDNAのシーケンスは再シーケンスと呼ばれます。目的は、特に関心のある領域でバリアントを見つけることです。

市場はアプリケーションに基づいて2つのカテゴリーに分けられます：スクリーニング、コンパニオン診断、その他の診断です。スクリーニング分野が市場を独占しており、予測期間中もその優位性は維持されると思われます。腫瘍DNAと生殖細胞系列DNAの次世代シーケンシング（NGS）は、診断、予後、治療の意味を急速に拡大するプレシジョン・オンコロジーの基盤です。腫瘍学の診断およびスクリーニング技術におけるNGSの使用は、市場の大幅な拡大をもたらしています。NGSパネル、装置、関連サービスのニーズは劇的に増加しています。

市場はエンドユーザー別に病院、診療所、研究所の3つに分類されます。検査施設が市場を独占しています。多くの診断ラボがNGSプラットフォームを導入して腫瘍ゲノムのプロファイリングを行い、医師が実用的な変異を特定し、それに応じて医薬品を調整するのを支援しています。

臨床腫瘍学次世代シーケンス市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国ごとにさらに分けられます。北米は、研究開発投資の増加やがん罹患率の上昇により、臨床腫瘍学次世代シーケンス市場の成長を支配すると予想されています。北米ではがんの罹患率が増加しているため、新しい診断・治療オプションが必要とされています。米国は医療およびバイオテクノロジー研究に多くの投資を行っています。

公共部門と商業部門の両方が毎年数十億米ドルを研究開発に投資し、新技術の改善と受容を促進しています。全米科学財団内の国立科学技術統計センター（NCSES）の新しいデータによると、米国で行われた研究開発（R&D）は2020年に総額7,170億米ドルに上る。欧州は、新しい医療技術の浸透が進んでいることから、臨床腫瘍学次世代シーケンスの第2位の市場になると予想されます。

臨床腫瘍学次世代シーケンサー市場-競合情勢：

次世代シーケンサー（NGS）技術の市場は大幅に拡大しています。医療分野の意思決定者は、適切な戦略や規制を策定するために、市場の成長と今後の動向に関する事実に基づいた知識を必要としているが、こうしたパターンの性質や規模についてはほとんど知られていないです。企業はその地位を高めるため、頻繁に提携や合併を行っています。大手企業は、アジア、ラテンアメリカ、アフリカなど、最新の医療技術への需要が高まっている新興国に進出しています。また、多くの新興企業が、より迅速なシーケンシング、より高い精度、より低い価格を提供する可能性のある新鮮な技術やアプローチをもたらしています。例えば、サーモフィッシャーサイエンティフィックは2022年4月12日、CE-IVDマークを取得したIon Torrent Genexus Dx Integrated Sequencerを発表しました。

目次

第1章 臨床腫瘍学次世代シーケンシング市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 臨床腫瘍学の次世代シーケンシングの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 臨床腫瘍学の次世代シーケンシング業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 臨床腫瘍学の次世代シーケンシング市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 臨床腫瘍学の次世代シーケンシング市場情勢

  • 臨床腫瘍学次世代シーケンシング市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 臨床腫瘍学次世代シーケンシング市場- ワークフロータイプ別

  • 概要
    • ワークフロータイプ別のセグメントシェア分析
    • NGSプリシーケンス
    • NGSシーケンス
    • NGSデータ分析

第8章 臨床腫瘍学の次世代シーケンス市場- テクノロジー別

  • 概要
    • セグメントシェア分析（テクノロジー別）
    • 全ゲノム配列決定
    • 全エクソームシーケンス
    • ターゲットシーケンシングとリシーケンシング

第9章 臨床腫瘍学の次世代シーケンス市場- アプリケーション別

  • 概要
    • アプリケーション別のセグメントシェア分析
    • ふるい分け
      • 散発性がん
      • 遺伝性がん
    • コンパニオン診断
    • その他の診断

第10章 臨床腫瘍学の次世代シーケンス市場- エンドユーザー別

  • 概要
    • セグメントシェア分析（テクノロジー別）
    • 病院
    • クリニック
    • 研究室

第11章 臨床腫瘍学の次世代シーケンス市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 臨床腫瘍学、次世代シーケンシング業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Illumina, Inc.
    • Thermo Fisher Scientific
    • F. Hoffmann-La Roche Ltd.
    • Agilent Technologies
    • Myriad Genetics
    • Foundation Medicine
    • Paradigm Diagnostics
    • Partek, Inc.
    • Pacific Bioscience
    • Qiagen NV
    • Beijing Genomics Institute（BGI）
    • Perkin Elmer
    • Oxford Nanopore Technologies Ltd.
    • Caris Life Sciences
    • Eurofins Scientific SE

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Clinical Oncology Next Generation Sequencing Market: Workflow Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Workflow Type
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Workflow Type 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Technology 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Application 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by End-User 2018-2030 (USD Million)
  • TABLE Clinical Oncology Next Generation Sequencing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Clinical Oncology Next Generation Sequencing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Workflow Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Clinical Oncology Next Generation Sequencing Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Clinical Oncology Next Generation Sequencing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Workflow Type segment market share analysis, 2022 & 2030
  • FIGURE Workflow Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Europe Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Asia Pacific Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Latin America Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE Middle East and Africa Clinical Oncology Next Generation Sequencing Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE Germany Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE India Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE Brazil Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Clinical Oncology Next Generation Sequencing Market share analysis by country, 2022
  • FIGURE Saudi Arabia Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Clinical Oncology Next Generation Sequencing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1748

REPORT HIGHLIGHT

Clinical Oncology Next Generation Sequencing Market size was valued at USD 388.4 Million in 2022, expanding at a CAGR of 16.5% from 2023 to 2030.

Next-generation sequencing (NGS), also known as massively parallel sequencing, is a powerful method for capturing a vast quantity of genomic information about a tumor. The majority of NGS technologies rely on synthesis-based sequencing. NGS has recently been used in clinical oncology to advance individualized cancer treatment. NGS is utilized to find familial cancer mutation carriers, identify novel and rare cancer mutations, and offer molecular rationale for effective targeted therapy. With targeted therapies becoming the new standard of care in oncology, NGS-driven companion diagnostics are generally expected to influence therapy selection to enhance patient outcomes.

Clinical Oncology Next Generation Sequencing Market- Market Dynamics

The rising prevalence of cancer is expected to drive the growth of the Clinical Oncology Next Generation Sequencing market.

As the prevalence of cancer rises, there is more need to better understand the disease and discover novel medicines. Next-generation sequencing (NGS) assays are quickly becoming the preferred option in the treatment of advanced cancer patients. NGS assays use high-throughput DNA sequencing technology to sequence the complete genome, the full exome, or certain gene exons (targeted panels). In the United States in 2020, 1,603,844 new cancer cases were reported and 602,347 people died of cancer. For every 100,000 people, 403 new cancer cases were reported and 144 people died of cancer. 2020 is the latest year for which incidence data are available, according to Centers for Disease Control and Prevention. Furthermore, Next Generation Sequencing opens the entrance to new oncological research discoveries, which may uncover new cancer progression pathways and processes. It provides growth opportunities for the market. However, the high cost of initial investment required for NGS technology and infrastructure can restrict market growth,

Clinical Oncology Next Generation Sequencing Market- Key Insights

  • As per the analysis shared by our research analyst, the global Clinical Oncology Next Generation Sequencing market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2023-2030)
  • The Clinical Oncology Next Generation Sequencing market is predicted to expand rapidly as a result of growing technological advancements and increased research spending.
  • Based on Workflow segmentation, NGS Sequencing was predicted to show maximum market share in the year 2022
  • Based on Technology segmentation, Targeted Sequencing, and resequencing were the leading type in 2022
  • Based on Application segmentation, Screening was the leading type in 2022
  • Based on End-User segmentation, Screening was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Clinical Oncology Next Generation Sequencing Market- Segmentation Analysis:

The Global Clinical Oncology Next Generation Sequencing Market is segmented on the basis of Workflow Type, Application, Technology, End-User, and Region.

The market is divided into three categories based on Workflow: NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis. The NGS Sequencing segment dominates the market. NGS refers to a class of current sequencing technologies that enable significantly faster and less expensive DNA and RNA sequencing than older approaches. These technologies have the ability to sequence millions to billions of DNA molecules at the same time.

The market is divided into three categories based on Technology: Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing and resequencing. Targeted Sequencing and resequencing segment dominates the market growth. Rather than sequencing the entire genome, targeted sequencing focuses on certain genes or regions of interest that have been linked to disease or are suspected to be linked to disease. The sequencing of previously sequenced DNA is referred to as resequencing. The purpose is to find variants, particularly in areas of interest.

The market is divided into two categories based on application: Screening, Companion Diagnostics, and other diagnostics. The Screening sector dominates the market and is likely to maintain its dominance during the forecast period. Next-generation sequencing (NGS) of tumor and germline DNA is foundational for precision oncology, with rapidly expanding diagnostic, prognostic, and therapeutic implications. The use of NGS in oncology diagnostic and screening techniques has resulted in significant market expansion. The need for NGS panels, equipment, and related services has increased dramatically.

The market is divided into three categories based on End-User: Hospitals, Clinics, and Laboratories. Laboratories dominate the market. Many diagnostic laboratories have implemented NGS platforms to provide tumor genomic profiling, assisting doctors in identifying actionable mutations and tailoring medicines accordingly.

Clinical Oncology Next Generation Sequencing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Clinical Oncology next-generation Sequencing market, due to increasing R&D investment, and the Rising Burden of Cancer. The increased incidence of cancer in North America needs novel diagnostic and treatment options. The United States invests much in medical and biotechnology research.

Both the public and commercial sectors invest billions of dollars in R&D each year, fueling improvements and the acceptance of new technology. New data from the National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation indicate that research and experimental development (R&D) performed in the United States totaled USD 717.0 billion in 2020. Europe is expected to be the second-largest market for Clinical Oncology Generation Sequencing, due to increasing penetration of new medical technologies.

Clinical Oncology Next Generation Sequencing Market- Competitive Landscape:

The market for next-generation sequencing (NGS) technologies has expanded substantially. Decision-makers in health care require factual knowledge of market growth and future trends in order to design suitable strategies and regulations, yet little is known about the nature and magnitude of these patterns. Companies frequently collaborate or merge to boost their position. Major firms are expanding their presence into emerging countries in Asia, Latin America, and Africa, where there is a growing demand for modern medical technologies. Also, a number of startups bring fresh technology or approaches to the table, which may offer faster sequencing, higher accuracy, or lower prices. For example, On April 12, 2022, Thermo Fisher Scientific recently launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that delivers results in one day.

Recent Developments:

In December 2021, Roche nowadays announced the launch of the AVENIO Edge System, a core component of Roche's strategy to advance sequencing technologies. Built on best-in-class foundational capabilities to deliver a fully automated, integrated sequencing solution. Roche is committed to developing diagnostic solutions with the goal of providing the healthcare community with faster and more accurate medical information to predict risk and detect disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET KEY PLAYERS

  • Illumina, Inc.
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies
  • Myriad Genetics
  • Foundation Medicine
  • Paradigm Diagnostics
  • Partek, Inc.
  • Pacific Bioscience
  • Qiagen N.V.
  • Beijing Genomics Institute (BGI)
  • Perkin Elmer
  • Oxford Nanopore Technologies Ltd.
  • Caris Life Sciences
  • Eurofins Scientific S.E.

GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW TYPE

  • NGS Pre-Sequencing
  • NGS Sequencing
  • NGS Data Analysis

GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing & Resequencing

GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

  • Screening
  • Sporadic Cancer
  • Inherited Cancer
  • Companion Diagnostics
  • Other Diagnostics

GLOBAL CLINICAL ONCOLOGY NEXT-GENERATION SEQUENCING MARKET, BY END-USER

  • Hospitals
  • Clinics
  • Laboratories

GLOBAL CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Clinical Oncology Next Generation Sequencing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Oncology Next Generation Sequencing Market Snippet by Workflow Type
    • 2.1.2. Clinical Oncology Next Generation Sequencing Market Snippet by Technology
    • 2.1.3. Clinical Oncology Next Generation Sequencing Market Snippet by Application
    • 2.1.4. Clinical Oncology Next Generation Sequencing Market Snippet by End-User
    • 2.1.5. Clinical Oncology Next Generation Sequencing Market Snippet by Country
    • 2.1.6. Clinical Oncology Next Generation Sequencing Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Oncology Next Generation Sequencing Key Market Trends

  • 3.1. Clinical Oncology Next Generation Sequencing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Oncology Next Generation Sequencing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Oncology Next Generation Sequencing Market Opportunities
  • 3.4. Clinical Oncology Next Generation Sequencing Market Future Trends

4. Clinical Oncology Next Generation Sequencing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Oncology Next Generation Sequencing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Oncology Next Generation Sequencing Market Landscape

  • 6.1. Clinical Oncology Next Generation Sequencing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Oncology Next Generation Sequencing Market - By Workflow Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Workflow Type, 2022 & 2030 (%)
    • 7.1.2. NGS Pre-Sequencing
    • 7.1.3. NGS Sequencing
    • 7.1.4. NGS Data Analysis

8. Clinical Oncology Next Generation Sequencing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 8.1.2. Whole Genome Sequencing
    • 8.1.3. Whole Exome Sequencing
    • 8.1.4. Targeted Sequencing & Resequencing

9. Clinical Oncology Next Generation Sequencing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Screening
      • 9.1.2.1. Sporadic Cancer
      • 9.1.2.2. Inherited Cancer
    • 9.1.3. Companion Diagnostics
    • 9.1.4. Other Diagnostics

10. Clinical Oncology Next Generation Sequencing Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Laboratories

11. Clinical Oncology Next Generation Sequencing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Clinical Oncology Next Generation Sequencing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Workflow Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Clinical Oncology Next Generation Sequencing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Illumina, Inc.
    • 12.2.2. Thermo Fisher Scientific
    • 12.2.3. F. Hoffmann-La Roche Ltd.
    • 12.2.4. Agilent Technologies
    • 12.2.5. Myriad Genetics
    • 12.2.6. Foundation Medicine
    • 12.2.7. Paradigm Diagnostics
    • 12.2.8. Partek, Inc.
    • 12.2.9. Pacific Bioscience
    • 12.2.10. Qiagen N.V.
    • 12.2.11. Beijing Genomics Institute (BGI)
    • 12.2.12. Perkin Elmer
    • 12.2.13. Oxford Nanopore Technologies Ltd.
    • 12.2.14. Caris Life Sciences
    • 12.2.15. Eurofins Scientific S.E.

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us